论文部分内容阅读
目的:探讨中药内服结合骨肽治疗原发性骨质疏松症的疗效。方法:筛选了60例骨质疏松症患者,随机分为观察组及对照组各30例。观察组采用自拟中药内服联合骨肽治疗,对照组采用碳酸钙D3片联合骨肽治疗,观察比较两组疗效。结果:观察组和对照组患者疼痛的缓解率分别为83.3%和66.7%,脊柱屈伸功能受限缓解率分别为76.5%和64.7%,腰背压痛、叩击痛缓解率分别为72.2%和62.5%。两组比较差异有统计学意义(P<0.05)。结论:中药内服联合骨肽治疗骨质疏松症对临床症状及体征的改善具有明显的效果。
Objective: To investigate the curative effect of traditional Chinese medicine combined with bone peptide in the treatment of primary osteoporosis. Methods: Sixty osteoporosis patients were selected and randomly divided into observation group and control group with 30 cases each. The observation group was treated with self-made Chinese medicine Oral administration of bone peptide, while the control group was treated with calcium carbonate and bone peptide. The curative effect was observed and compared between the two groups. Results: The pain relief rates of the observation group and the control group were 83.3% and 66.7%, respectively. The relief rates of spinal flexion and extension were 76.5% and 64.7% respectively. The relief rates of low back pain and percussion pain were 72.2% and 62.5% respectively %. The difference between the two groups was statistically significant (P <0.05). Conclusion: Oral administration of Chinese medicine combined with osteopeptide osteoporosis has obvious effect on the improvement of clinical symptoms and signs.